Advertisement

Sedation and Analgesia

  • Paul Ellis Marik
Chapter

Abstract

Anxiety is an almost universal feature of ICU patients. Clinically significant anxiety has been reported in up to 70% of ICU patients. Severe anxiety is not limited to mechanically ventilated patients; indeed Treggiari-Venzi and colleagues demonstrated that up to 30% of non-intubated SICU patients had severe anxiety.1 Consequently, sedation is an integral component of the management of the ICU patient. The primary objective of sedation is to allay anxiety, enhance patient comfort, promote sleep, and facilitate mechanical ventilation. The desirable level of sedation/hypnosis will depend in large part upon the patient’s acute disease process as well as the need for mechanical ventilation. However, the ideal level of sedation is one from which the patient can be easily aroused with maintenance of the normal sleep–wake cycle.

Keywords

Neuromuscular Blockade Deep Sedation Severe Anxiety Alcohol Withdrawal Syndrome Sedation Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, et al. Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med. 1996;22:1186–1190.PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–141.PubMedCrossRefGoogle Scholar
  3. 3.
    Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone–alphadolone. Br Med J. 1974;2:656–659.PubMedCrossRefGoogle Scholar
  4. 4.
    De Jonghe B, Cook D, Appere-De-Vecchi C, et al. Using and understanding sedation scoring systems: a systematic review. Intensive Care Med. 2000;26:275–285.PubMedCrossRefGoogle Scholar
  5. 5.
    Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation–Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338–1344.PubMedCrossRefGoogle Scholar
  6. 6.
    Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation–Sedation Scale (RASS). JAMA. 2003;289:2983–2991.PubMedCrossRefGoogle Scholar
  7. 7.
    Kollef MH, Levy NT, Ahrens TS, et al. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541–548.PubMedCrossRefGoogle Scholar
  8. 8.
    Treggiari MM, Romand JA, Yanez ND, et al. Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med. 2009;37:2517–2534.CrossRefGoogle Scholar
  9. 9.
    Gunther ML, Jackson JC, Ely EW. The cognitive consequences of critical illness: practical recommendations for screening and assessment. Crit Care Clin. 2007;23:491–506.PubMedCrossRefGoogle Scholar
  10. 10.
    Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753–1762.PubMedCrossRefGoogle Scholar
  11. 11.
    Pandharipande P, Cotton BA, Shintani A, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma. 2008;65:34–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104:21–26.PubMedCrossRefGoogle Scholar
  13. 13.
    Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients. JAMA. 2009;301:489–499.PubMedCrossRefGoogle Scholar
  14. 14.
    Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009;35:282–290.PubMedCrossRefGoogle Scholar
  15. 15.
    Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients. The MENDS randomized controlled trial. JAMA. 2007;298:2644–2653.PubMedCrossRefGoogle Scholar
  16. 16.
    Marik PE. Propofol: therapeutic indications and side effects. Curr Pharm Design. 2004;10:3639–3649.CrossRefGoogle Scholar
  17. 17.
    Arroliga AC, Shehab N, McCarthy K, et al. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med. 2004;32:1709–1714.PubMedCrossRefGoogle Scholar
  18. 18.
    Yaucher NE, Fish JT, Smith HW, et al. Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy. 2003;23:1094–1099.PubMedCrossRefGoogle Scholar
  19. 19.
    Yahwak JA, Riker RR, Fraser GL, et al. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy. 2008;28:984–991.PubMedCrossRefGoogle Scholar
  20. 20.
    Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27:2609–2615.PubMedCrossRefGoogle Scholar
  21. 21.
    Arias-Rivera S, Sanchez-Sanchez MM, Santos-Diaz R, et al. Effect of a nursing-implemented sedation protocol on weaning outcome. Crit Care Med. 2008;36:2054–2060.PubMedCrossRefGoogle Scholar
  22. 22.
    Kress JP, Pohlman AS, O’Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471–1477.PubMedCrossRefGoogle Scholar
  23. 23.
    Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371:126–134.PubMedCrossRefGoogle Scholar
  24. 24.
    Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373:1874–1882.PubMedCrossRefGoogle Scholar
  25. 25.
    Akada S, Takeda S, Yoshida Y, et al. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesth Analg. 2008;107:167–170.PubMedCrossRefGoogle Scholar
  26. 26.
    Lagneau F, D’honneur G, Plaud B, et al. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med. 2002;28:1735–1741.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations